21 insiders reported 714 Form 4 transactions for MADRIGAL PHARMACEUTICALS, INC. (MDGL) over the past 18 months (most recent 2026-06-18). Recent activity: BAKER BROS. ADVISORS LP (Director) Buy 908 shares, Baker Bros. Advisors (GP) LLC (Director) Buy 908 shares, BAKER JULIAN (Director) Buy 908 shares, Baker Brothers Life Sciences LP (Director) Buy 908 shares, FOUSE JACQUALYN A (Director) Buy 454 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-18 | BAKER BROS. ADVISORS LP | Director | Buy | 908 | $0 |
| 2026-06-18 | Baker Bros. Advisors (GP) LLC | Director | Buy | 908 | $0 |
| 2026-06-18 | BAKER JULIAN | Director | Buy | 908 | $0 |
| 2026-06-18 | Baker Brothers Life Sciences LP | Director | Buy | 908 | $0 |
| 2026-06-18 | FOUSE JACQUALYN A | Director | Buy | 454 | $0 |
| 2026-06-18 | Taub Rebecca | Director | Buy | 454 | $0 |
| 2026-06-18 | Levy Richard S | Director | Buy | 454 | $0 |
| 2026-06-18 | BAKER FELIX | Director | Buy | 908 | $0 |
| 2026-06-18 | Daly James M | Director | Buy | 454 | $0 |
| 2026-06-18 | Baker Bros. Advisors (GP) LLC | Director | Buy | 908 | $0 |
| 2026-06-18 | Brennan Daniel J. | Director | Buy | 404 | $0 |
| 2026-06-18 | BAKER JULIAN | Director | Buy | 908 | $0 |
| 2026-06-18 | BAKER FELIX | Director | Buy | 908 | $0 |
| 2026-06-18 | BAKER BROS. ADVISORS LP | Director | Buy | 908 | $0 |
| 2026-06-18 | Baker Brothers Life Sciences LP | Director | Buy | 908 | $0 |
| 2026-06-18 | 667, L.P. | Director | Buy | 908 | $0 |
| 2026-06-18 | 667, L.P. | Director | Buy | 908 | $0 |
| 2026-06-01 | Soergel David | Chief Medical Officer | Sell | 1,042 | $516,561 |
| 2026-05-22 | Levy Richard S | Director | Sell | 40 | $20,267 |
| 2026-05-22 | Levy Richard S | Director | Sell | 343 | $176,532 |
| 2026-05-22 | Levy Richard S | Director | Sell | 151 | $77,064 |
| 2026-05-22 | Levy Richard S | Director | Sell | 610 | $311,952 |
| 2026-05-22 | Levy Richard S | Director | Sell | 439 | $224,988 |
| 2026-05-22 | Levy Richard S | Director | Sell | 40 | $20,519 |
| 2026-05-22 | Levy Richard S | Director | Sell | 320 | $162,637 |
Source: SEC Form 4 filings · as of 2026-06-18